Literature DB >> 15818095

Transfusion-related acute lung injury: definition and review.

Pearl Toy1, Mark A Popovsky, Edward Abraham, Daniel R Ambruso, Leslie G Holness, Patricia M Kopko, Janice G McFarland, Avery B Nathens, Christopher C Silliman, David Stroncek.   

Abstract

BACKGROUND: Transfusion-related acute lung injury (TRALI) is now the leading cause of transfusion-associated mortality, even though it is probably still underdiagnosed and underreported. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE ACTION: The National Heart, Lung, and Blood Institute convened a working group to identify areas of research needed in TRALI. The working group identified the immediate need for a common definition and thus developed the clinical definition in this report. MAJOR CONCEPTS IN THE DEFINITION: The major concept is that TRALI is defined as new acute lung injury occurring during or within 6 hrs after a transfusion, with a clear temporal relationship to the transfusion. Also, another important concept is that acute lung injury temporally associated with multiple transfusions can be TRALI, because each unit of blood or blood component can carry one or more of the possible causative agents: antileukocyte antibody, biologically active substances, and other yet unidentified agents. RECOMMENDATION: Using the definition in this report, clinicians can diagnose and report TRALI cases to the blood bank; importantly, researchers can use this definition to determine incidence, pathophysiology, and strategies to prevent this leading cause of transfusion-associated mortality.

Entities:  

Mesh:

Year:  2005        PMID: 15818095     DOI: 10.1097/01.ccm.0000159849.94750.51

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  143 in total

1.  Transfusion-Related Acute Lung Injury: Incidence, Pathogenesis and the Role of Multicomponent Apheresis in Its Prevention.

Authors:  Mark A Popovsky
Journal:  Transfus Med Hemother       Date:  2008-03-10       Impact factor: 3.747

2.  Transfusion-related acute lung injury: incidence and risk factors.

Authors:  Pearl Toy; Ognjen Gajic; Peter Bacchetti; Mark R Looney; Michael A Gropper; Rolf Hubmayr; Clifford A Lowell; Philip J Norris; Edward L Murphy; Richard B Weiskopf; Gregory Wilson; Monique Koenigsberg; Deanna Lee; Randy Schuller; Ping Wu; Barbara Grimes; Manish J Gandhi; Jeffrey L Winters; David Mair; Nora Hirschler; Rosa Sanchez Rosen; Michael A Matthay
Journal:  Blood       Date:  2011-11-23       Impact factor: 22.113

3.  Involvement of the Rho kinases in mediating sepsis.

Authors:  T C Tai
Journal:  J Thorac Dis       Date:  2012-02       Impact factor: 2.895

4.  Identification of hemopexin as an anti-inflammatory factor that inhibits synergy of hemoglobin with HMGB1 in sterile and infectious inflammation.

Authors:  Tian Lin; Fatima Sammy; Huan Yang; Sujatha Thundivalappil; Judith Hellman; Kevin J Tracey; H Shaw Warren
Journal:  J Immunol       Date:  2012-07-06       Impact factor: 5.422

Review 5.  Leucoreduction of blood components: an effective way to increase blood safety?

Authors:  Maria Bianchi; Stefania Vaglio; Simonetta Pupella; Giuseppe Marano; Giuseppina Facco; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-12-16       Impact factor: 3.443

6.  Prospective study on the clinical course and outcomes in transfusion-related acute lung injury*.

Authors:  Mark R Looney; Nareg Roubinian; Ognjen Gajic; Michael A Gropper; Rolf D Hubmayr; Clifford A Lowell; Peter Bacchetti; Gregory Wilson; Monique Koenigsberg; Deanna C Lee; Ping Wu; Barbara Grimes; Philip J Norris; Edward L Murphy; Manish J Gandhi; Jeffrey L Winters; David C Mair; Randy M Schuller; Nora V Hirschler; Rosa Sanchez Rosen; Michael A Matthay; Pearl Toy
Journal:  Crit Care Med       Date:  2014-07       Impact factor: 7.598

7.  A case of transfusion-related acute lung injury induced by anti-human leukocyte antigen antibodies in acute leukemia.

Authors:  Sun Mi Jin; Moon Ju Jang; Ji Young Huh; Myoung Hee Park; Eun Young Song; Doyeun Oh
Journal:  Korean J Hematol       Date:  2012-12-24

8.  Recipient clinical risk factors predominate in possible transfusion-related acute lung injury.

Authors:  Pearl Toy; Peter Bacchetti; Barbara Grimes; Ognjen Gajic; Edward L Murphy; Jeffrey L Winters; Michael A Gropper; Rolf D Hubmayr; Michael A Matthay; Gregory Wilson; Monique Koenigsberg; Deanna C Lee; Nora V Hirschler; Clifford A Lowell; Randy M Schuller; Manish J Gandhi; Philip J Norris; David C Mair; Rosa Sanchez Rosen; Mark R Looney
Journal:  Transfusion       Date:  2014-12-08       Impact factor: 3.157

9.  The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill.

Authors:  Guangxi Li; Craig E Daniels; Marija Kojicic; Tami Krpata; Greg A Wilson; Jeffrey L Winters; S Breanndan Moore; Ognjen Gajic
Journal:  Transfusion       Date:  2008-10-14       Impact factor: 3.157

10.  Mirasol Pathogen Reduction Technology treatment does not affect acute lung injury in a two-event in vivo model caused by stored blood components.

Authors:  C C Silliman; S Y Khan; J Bradley Ball; M R Kelher; S Marschner
Journal:  Vox Sang       Date:  2009-11-25       Impact factor: 2.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.